# British Heart Foundation

**Type:** Funders  
**Canonical URL:** https://scholariq.org/funders/british-heart-foundation/

## Facts

| Field | Value |
| --- | --- |
| Country | GB |
| Description | UK charity for heart health |
| OpenAlex ID | https://openalex.org/F4320319992 |
| ROR ID | https://ror.org/02wdwnk04 |
| Works | 53,274 |

## Funder papers

Showing 15 of 25.

- [Non-invasive detection of coronary inflammation using computed tomography and prediction of residual cardiovascular risk (the CRISP CT study): a post-hoc analysis of prospective outcome data](https://scholariq.org/papers/non-invasive-detection-of-coronary-inflammation-using-computed-tomography-and/)
- [Efficacy of Dapagliflozin on Renal Function and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction](https://scholariq.org/papers/efficacy-of-dapagliflozin-on-renal-function-and-outcomes-in-patients-with-heart/)
- [Effect of Spironolactone on Left Ventricular Mass and Aortic Stiffness in Early-Stage Chronic Kidney Disease](https://scholariq.org/papers/effect-of-spironolactone-on-left-ventricular-mass-and-aortic-stiffness-in-early/)
- [Inflammatory risk and cardiovascular events in patients without obstructive coronary artery disease: the ORFAN multicentre, longitudinal cohort study](https://scholariq.org/papers/inflammatory-risk-and-cardiovascular-events-in-patients-without-obstructive/)
- [Long-term kidney outcomes of semaglutide in obesity and cardiovascular disease in the SELECT trial](https://scholariq.org/papers/long-term-kidney-outcomes-of-semaglutide-in-obesity-and-cardiovascular-disease/)
- [Dapagliflozin in HFrEF Patients Treated With Mineralocorticoid Receptor Antagonists](https://scholariq.org/papers/dapagliflozin-in-hfref-patients-treated-with-mineralocorticoid-receptor/)
- [Cost-effectiveness of cardiovascular magnetic resonance in the diagnosis of coronary heart disease: an economic evaluation using data from the CE-MARC study](https://scholariq.org/papers/cost-effectiveness-of-cardiovascular-magnetic-resonance-in-the-diagnosis-of/)
- [Standardized measurement of coronary inflammation using cardiovascular computed tomography: integration in clinical care as a prognostic medical device](https://scholariq.org/papers/standardized-measurement-of-coronary-inflammation-using-cardiovascular-computed/)
- [Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial](https://scholariq.org/papers/effects-of-empagliflozin-on-progression-of-chronic-kidney-disease-a-prespecified/)
- [Effects of rare kidney diseases on kidney failure: a longitudinal analysis of the UK National Registry of Rare Kidney Diseases (RaDaR) cohort](https://scholariq.org/papers/effects-of-rare-kidney-diseases-on-kidney-failure-a-longitudinal-analysis-of-the/)
- [Association of air pollution with dementia: a systematic review with meta-analysis including new cohort data from China](https://scholariq.org/papers/association-of-air-pollution-with-dementia-a-systematic-review-with-meta/)
- [Spironolactone versus placebo in patients undergoing maintenance dialysis (ACHIEVE): an international, parallel-group, randomised controlled trial](https://scholariq.org/papers/spironolactone-versus-placebo-in-patients-undergoing-maintenance-dialysis/)
- [Stratified medicine using invasive coronary function testing in angina: A cost-effectiveness analysis of the British Heart Foundation CorMicA trial](https://scholariq.org/papers/stratified-medicine-using-invasive-coronary-function-testing-in-angina-a-cost/)
- [Risk Factors and Prediction Models for Incident Heart Failure with Reduced and Preserved Ejection Fraction](https://scholariq.org/papers/risk-factors-and-prediction-models-for-incident-heart-failure-with-reduced-and/)
- [Safety and Efficacy of Intravenous Ferric Derisomaltose Compared to Iron Sucrose for Iron Deficiency Anemia in Patients with Chronic Kidney Disease With and Without Heart Failure](https://scholariq.org/papers/safety-and-efficacy-of-intravenous-ferric-derisomaltose-compared-to-iron-sucrose/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.